BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 32891787)

  • 1. Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease.
    Faria M; de Pinho MN
    Transl Res; 2021 Mar; 229():115-134. PubMed ID: 32891787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance.
    Daneshamouz S; Eduok U; Abdelrasoul A; Shoker A
    NanoImpact; 2021 Jan; 21():100299. PubMed ID: 35559786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and clinical implications of protein-bound uremic toxins.
    Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
    Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome.
    van Gelder MK; Middel IR; Vernooij RWM; Bots ML; Verhaar MC; Masereeuw R; Grooteman MP; Nubé MJ; van den Dorpel MA; Blankestijn PJ; Rookmaaker MB; Gerritsen KGF
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32272776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved dialytic removal of protein-bound uremic toxins by intravenous lipid emulsion in chronic kidney disease rats.
    Shi Y; Zhang Y; Tian H; Wang Y; Shen Y; Zhu Q; Ding F
    Nephrol Dial Transplant; 2019 Nov; 34(11):1842-1852. PubMed ID: 31071223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future Avenues to Decrease Uremic Toxin Concentration.
    Vanholder RC; Eloot S; Glorieux GL
    Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: Hope or pipe dream?
    Florens N; Yi D; Juillard L; Soulage CO
    Biochimie; 2018 Jan; 144():1-8. PubMed ID: 28987629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adsorption- and Displacement-Based Approaches for the Removal of Protein-Bound Uremic Toxins.
    Rodrigues FSC; Faria M
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal versus continuous versus intermittent therapies for removal of uremic toxins.
    Clark WR; Henderson LW
    Kidney Int Suppl; 2001 Feb; 78():S298-303. PubMed ID: 11169030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins.
    Ciceri P; Cozzolino M
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremic Toxins and their Relation to Dialysis Efficacy.
    Clark WR; Dehghani NL; Narsimhan V; Ronco C
    Blood Purif; 2019; 48(4):299-314. PubMed ID: 31563911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut-Derived Protein-Bound Uremic Toxins.
    Graboski AL; Redinbo MR
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adsorption of Protein-Bound Uremic Toxins Using Activated Carbon through Direct Hemoperfusion in vitro.
    Yamamoto S; Ito T; Sato M; Goto S; Kazama JJ; Gejyo F; Narita I
    Blood Purif; 2019; 48(3):215-222. PubMed ID: 31055586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population.
    Snauwaert E; Holvoet E; Van Biesen W; Raes A; Glorieux G; Vande Walle J; Roels S; Vanholder R; Askiti V; Azukaitis K; Bayazit A; Canpolat N; Fischbach M; Godefroid N; Krid S; Litwin M; Obrycki L; Paglialonga F; Ranchin B; Samaille C; Schaefer F; Schmitt CP; Spasojevic B; Stefanidis CJ; Van Dyck M; Van Hoeck K; Collard L; Eloot S; Shroff R
    Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 31022857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibuprofen-Immobilized Thin Films: A Novel Approach to Improve the Clearance of Protein-Bound Uremic Toxins.
    Rodrigues FSC; Brilhante D; Macêdo A; Pires RF; Faria M
    ACS Appl Mater Interfaces; 2024 Feb; 16(5):6589-6604. PubMed ID: 38282580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
    Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
    Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the efficacy of AST-120 (KREMEZIN
    Asai M; Kumakura S; Kikuchi M
    Ren Fail; 2019 Nov; 41(1):47-56. PubMed ID: 30732506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for a New Classification of Solutes of Interest in Chronic Kidney Disease and Hemodialysis.
    Reis T; Hutchison C; de Assis Rocha Neves F; Zawadzki B; Zanella M; Ronco C; Rosner MH
    Blood Purif; 2023; 52(3):242-254. PubMed ID: 36657410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.